{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:13:27Z","timestamp":1788480807562,"version":"build-2803163510"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:00Z","timestamp":1778889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rbmojournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive BioMedicine Online"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.rbmo.2026.105783","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T23:31:07Z","timestamp":1779319867000},"page":"105783","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intermediate FMR1 cytosine\u2012guanine\u2012guanine repeats do not impair assisted reproductive technology outcomes in a large real-world cohort"],"prefix":"10.1016","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-4211-9526","authenticated-orcid":false,"given":"Adi","family":"Dayan-Schwartz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitzan Dana","family":"Sela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ido","family":"Izhaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morad","family":"Khayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shira","family":"Baram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronit","family":"Beck-Fruchter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rbmo.2026.105783_bib0001","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13048-024-01425-0","article-title":"Correlation of FMR4 expression levels to ovarian reserve markers in FMR1 premutation carriers","volume":"17","author":"Agusti","year":"2024","journal-title":"J Ovarian Res"},{"key":"10.1016\/j.rbmo.2026.105783_bib0002","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.3390\/genes15081008","article-title":"Prevalence of the FMR1 Gene Premutation in Young Women with a Diminished Ovarian Reserve Included in an IVF Program: Implications for Clinical Practice","volume":"15","author":"Agust\u00ed","year":"2024","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.rbmo.2026.105783_bib0003","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1038\/s41436-021-01177-y","article-title":"Refining the risk for fragile X-associated primary ovarian insufficiency (FXPOI) by FMR1 CGG repeat size","volume":"23","author":"Allen","year":"2021","journal-title":"Genet Med"},{"key":"10.1016\/j.rbmo.2026.105783_bib0004","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1093\/humrep\/dex090","article-title":"The ovarian response in fragile X patients and premutation carriers undergoing IVF-PGD: reappraisal","volume":"32","author":"Avraham","year":"2017","journal-title":"Hum Reprod"},{"key":"10.1016\/j.rbmo.2026.105783_bib0005","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.fertnstert.2016.02.011","article-title":"Is FMR1 CGG repeat length a predictor of in vitro fertilization stimulation response or outcome?","volume":"105","author":"Banks","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.rbmo.2026.105783_bib0006","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.fertnstert.2009.04.047","article-title":"The effect of CGG repeat number on ovarian response among fragile X premutation carriers undergoing preimplantation genetic diagnosis","volume":"94","author":"Bibi","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.rbmo.2026.105783_bib0007","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-93489-x","article-title":"Dysregulation of anti-Mullerian hormone expression levels in mural granulosa cells of FMR1 premutation carriers","volume":"11","author":"Friedman-Gohas","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.rbmo.2026.105783_bib0008","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.rbmo.2016.11.001","article-title":"The \u201cnormal\u201d range of FMR1 triple CGG repeats may be associated with primary ovarian insufficiency in China","volume":"34","author":"Lu","year":"2017","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.rbmo.2026.105783_bib0009","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/humrep\/dex334","article-title":"The number of oocytes retrieved during IVF: a balance between efficacy and safety","volume":"33","author":"Magnusson","year":"2018","journal-title":"Hum Reprod"},{"key":"10.1016\/j.rbmo.2026.105783_bib0010","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1001\/jama.295.12.1428","article-title":"The role of X inactivation and cellular mosaicism in women\u2019s health and sex-specific diseases","volume":"295","author":"Migeon","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.rbmo.2026.105783_bib0011","first-page":"1252","article-title":"Familial transmission of the FMR1 CGG repeat","volume":"59","author":"Nolin","year":"1996","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.rbmo.2026.105783_bib0012","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.rbmo.2018.11.009","article-title":"Does theFMR1 gene affect IVF success?","volume":"38","author":"Pastore","year":"2019","journal-title":"Reproductive BioMedicine Online"},{"key":"10.1016\/j.rbmo.2026.105783_bib0013","doi-asserted-by":"crossref","DOI":"10.1002\/ajmg.a.63479","article-title":"Stratification of the risk of ovarian dysfunction by studying the complexity of intermediate and premutation alleles of the FMR1 gene","volume":"194","author":"Quilichini","year":"2024","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.rbmo.2026.105783_bib0014","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202200468RR","article-title":"Evidence for a fragile X messenger ribonucleoprotein 1 (FMR1) mRNA gain-of-function toxicity mechanism contributing to the pathogenesis of fragile X-associated premature ovarian insufficiency","volume":"36","author":"Rosario","year":"2022","journal-title":"FASEB J"},{"key":"10.1016\/j.rbmo.2026.105783_bib0015","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s10815-020-01774-x","article-title":"An explanation of the mechanisms underlying fragile X-associated premature ovarian insufficiency","volume":"37","author":"Rose","year":"2020","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.rbmo.2026.105783_bib0016","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1093\/humrep\/dev220","article-title":"Diminished ovarian reserve is not observed in infertility patients with high normal CGG repeats on the fragile X mental retardation 1 (FMR1) gene","volume":"30","author":"Schufreider","year":"2015","journal-title":"Hum Reprod"},{"key":"10.1016\/j.rbmo.2026.105783_bib0017","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMcp2116488","article-title":"Primary Ovarian Insufficiency","volume":"388","author":"Stuenkel","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rbmo.2026.105783_bib0018","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/humrep\/deh635","article-title":"Association of FMR1 repeat size with ovarian dysfunction","volume":"20","author":"Sullivan","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.rbmo.2026.105783_bib0019","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1093\/humrep\/deu095","article-title":"The significance of fragile X mental retardation gene 1 CGG repeat sizes in the normal and intermediate range in women with primary ovarian insufficiency","volume":"29","author":"Voorhuis","year":"2014","journal-title":"Hum Reprod"},{"key":"10.1016\/j.rbmo.2026.105783_bib0020","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/humrep\/deaf097.107","article-title":"The Istanbul consensus update: a revised ESHRE\/ALPHA consensus on oocyte and embryo static and dynamic morphological assessment\u2020,\u2021","volume":"40","author":"Coticchio","year":"2025","journal-title":"Hum Reprod"}],"container-title":["Reproductive BioMedicine Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147264832600324X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147264832600324X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:43:31Z","timestamp":1788479011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147264832600324X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S147264832600324X"],"URL":"https:\/\/doi.org\/10.1016\/j.rbmo.2026.105783","relation":{},"ISSN":["1472-6483"],"issn-type":[{"value":"1472-6483","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intermediate FMR1 cytosine\u2012guanine\u2012guanine repeats do not impair assisted reproductive technology outcomes in a large real-world cohort","name":"articletitle","label":"Article Title"},{"value":"Reproductive BioMedicine Online","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rbmo.2026.105783","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of Reproductive Healthcare Ltd.","name":"copyright","label":"Copyright"}],"article-number":"105783"}}